查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球等温线核酸扩增技术市场 - 2023-2030年
市场调查报告书
商品编码
1297824

全球等温线核酸扩增技术市场 - 2023-2030年

Global Isothermal Nucleic Acid Amplification Technology Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球等温核酸扩增技术市场在2022年达到33亿美元，预计到2030年将见证有利的增长，达到75亿美元。预计在2023-2030年预测期内，等温核酸扩增技术市场将呈现11.1%的复合增长率。

等温核酸扩增是一种在稳定的温度下快速有效地收集核酸系列的技术。核酸扩增技术在分子生物学和重组DNA方法中被采用。这些方法被作为识别和调查少量核酸的顶级做法。

市场动态

全球范围内传染病发病率的增长推动了预测期内全球等温核酸扩增技术市场的发展。

全球范围内传染病发病率的不断增长，正在推动预测期内全球等温核酸扩增技术（INAAT）市场的增长。例如，世界卫生组织在2022年10月24日至11月23日期间登记了超过5000名新鲜猴痘患者。此外，在2021年底，超过1170万人接受抗逆转录病毒治疗（ART）的结果，CDC通过美国总统的艾滋病应急计划对艾滋病毒护理和治疗的援助。

不断增长的老年人口为全球等温核酸扩增技术市场提供了前景广阔的增长机会。

不断增长的老年人口为全球等温核酸扩增市场提供了未来几年的增长机会。例如，根据联合国发布的《2022年世界人口前景》，80岁或以上的人的数量预计将增长三倍，从2022年的1.57亿增长到2050年的4.59亿。

COVID-19影响分析

COVID-19分析包括COVID前情景、COVID情景和COVID后情景，以及定价动态（包括大流行期间和之后的定价变化与COVID前情景的比较）、需求-供应谱（由于贸易限制、封锁和后续问题造成的需求和供应转移）、政府倡议（政府机构为振兴市场、部门或行业而采取的倡议）和制造商战略倡议（这里将涵盖制造商为缓解COVID问题所采取的措施）。

俄乌战争影响分析

这场战争对全球等温线核酸扩增市场产生了轻微的负面影响，因为自俄罗斯的攻击开始以来，世界卫生组织已经记录了703起对卫生基础设施的攻击。此外，随着俄罗斯武装部队深入邻国乌克兰的心脏地带，铝、铜、钢和塑料等关键原材料的成本，与一般通货膨胀分开，目前正威胁着白色商品的额外成本升级。然而，尽管发生了战争，乌克兰继续为病人提供必要的医疗服务。

全球经济衰退影响分析

医疗保健行业并非完全不受经济衰退的影响，因为医疗保健机构在过去的金融衰退中认为有解雇和就业。尽管如此，由于其基本性质，该行业确实比其他行业应对得更好。然而，随着通货膨胀的持续增加，衰退的危险威胁着市场。

由于全球发达国家的高通货膨胀率，对持续衰退的紧张程度上升，在过去两年中出现了普遍的成本激增。累积恶化的一般购买控制预计将特别影响增长中的经济体，并被认为在许多方面有帮助。

人工智能影响分析

人工智能估计会在未来几年内对全球等温核酸扩增市场产生积极影响。人工智能（AI）和物联网（IoT）技术（AIoT）的结合可能是自两个世纪前第一台商业制冰机发明以来对等温核酸扩增的最大破坏。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品类型分类的摘要
  • 按应用分类的摘要
  • 按技术分类
  • 按终端用户分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 用于储存目的的等温核酸扩增技术的需求上升。
      • 市场的发展。
    • 限制因素
      • 使用翻新设备的趋势日益明显
    • 机会
    • 政府倡议
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 监管分析
  • 价格分析
  • 专利分析
  • PEST分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • COVID-19之后的情况
    • COVID-19之后的情况
  • 在COVID-19中的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章 ：俄罗斯-乌克兰战争分析

第八章：全球经济衰退分析

第九章：人工智能影响分析

第十章：按产品类型

  • 仪器
  • 试剂

第十一章：按应用分类

  • 传染性疾病的诊断
  • 血液筛查
  • 癌症研究
  • 其他应用

第十二章：按技术分类

  • 基于核酸序列的扩增技术（NASBA）。
  • 单引物等温扩增(SPIA)
  • 尼克酶扩增反应(NEAR)
  • 依赖螺旋酶的扩增(HDA)
  • 转录介导的扩增 (TMA)
  • 环路介导的等温扩增（LAMP）。
  • 链式置换扩增（SDA）
  • 其他

第十三章 ：按终端用户

  • 医院和诊所
  • 诊断中心
  • 研究实验室
  • 其他

第十四章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第15章 ：竞争格局

  • 竞争格局
  • 市场份额分析
  • 合併和收购分析

第十六章 ：公司简介

  • Thermo Fisher Scientific Inc.
    • 公司概述
    • 产品类型组合和描述
    • 财务概况
    • 主要发展情况
  • bioMerieux
  • Becton, Dickinson & Company
  • Lucigen
  • Qiagen
  • Quidel Corporation
  • Eiken Chemical Co. Ltd
  • Tecan Genomics Inc.
  • Meridian Bioscience
  • OptiGene Limited

第十七章 ：附录

简介目录
Product Code: CD2081

Market Overview

The Global Isothermal Nucleic Acid Amplification Technology Market reached USD 3.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 7.5 billion by 2030. the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2023-2030.

Isothermal nucleic acid amplification is a technique that quickly and effectively collects nucleic acid series at a consistent temperature. Nucleic acid amplification technologies are employed in molecular biology and recombinant DNA approaches. These methods are employed as top practices in identifying and investigating a short number of nucleic acids.

Market Dynamics

The Growing Prevalence of Infectious Diseases Globally is Driving the Global Isothermal Nucleic Acid Amplification Technology Market in the Forecast Period.

The growing prevalence of infectious diseases globally is driving the global isothermal nucleic acid amplification technology (INAAT) market growth during the forecast period. For instance, the World Health Organization registered over 5,000 fresh monkeypox patients between October 24, 2022 to November 23, 2022. Moreover, at the end of 2021, over 11.7 million individuals were on Anti Retroviral Treatment (ART) outcome of the CDC's aid for HIV care and treatment via the U.S. President's Emergency Plan for AIDS Response.

The Growing Geriatric Population is Providing the Global Isothermal Nucleic Acid Amplification Technology Market With Prospective Growth Opportunities.

The growing geriatric population is presenting the global isothermal nucleic acid amplification market with prospective growth opportunities in the upcoming years. For instance, according to the World Population Prospects 2022, from the UN, the number of individuals aged 80 or above is anticipated to grow triple fold, from 157 million in 2022 to 459 million by 2050.

COVID-19 Impact Analysis

The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Russia-Ukraine War Impact Analysis

The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.

Global Recession Impact Analysis

The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.

The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.

Artificial Intelligence Impact Analysis

Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.

Segment Analysis

The global isothermal nucleic acid amplification technology market is segmented based on product type, applications, technology and region.

The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.

Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.

Geographical Analysis

Europe is Estimated to Hold the Second-largest Share of the Global Isothermal Nucleic Acid Amplification Technology Market During the Forecast Period.

Owing to the increasing number of cancer deaṭhs and growing efforts to fight against cancer Europe is estimated to hold around 25.9% of the global isothermal nucleic acid amplification market by 2030. For instance, according to the 2022 edition of Health at a Glance, cancer is the second greatest reason for death in the EU behind cardiovascular disorders.

Between 30-50% of cancer patients' deaths are avoidable and mortality can also be reduced through earlier detection and the condition of better punctual and effective therapies. Europe's Beating Cancer Plan strives to decrease the load of cancer and manage cancer-related imbalances between and within nations, with efforts to help, coordinate and complete the actions of Member States.

Competitive Landscape

The major global players in the market include: bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited and Thermo Fisher Scientific among others.

Why Purchase the Report?

  • To visualize the global isothermal nucleic acid amplification technology market segmentation based on product type, applications, technology, end user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of isothermal nucleic acid amplification technology market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 pages.

Target Audience 2023

  • Manufacturers / Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Applications
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
      • 4.1.1.2. Market Developments.
    • 4.1.2. Restraints
      • 4.1.2.1. The Growing Trend of Using Refurbished Equipment
    • 4.1.3. Opportunity
    • 4.1.4. Government Initiatives
    • 4.1.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. PEST Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario After COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Global Recession Analysis

9. Artificial Intelligence Impact Analysis

10. By Product Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.1.2. Market Attractiveness Index, By Product Type
  • 10.2. Instruments
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Reagents

11. By Applications

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 11.1.2. Market Attractiveness Index, By Applications
  • 11.2. Infectious Diseases Diagnostics*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Blood Screening
  • 11.4. Cancer Research
  • 11.5. Others

12. By Technology

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.1.2. Market Attractiveness Index, By Technology
  • 12.2. Nucleic Acid Sequence-based Amplification (NASBA)
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Single Primer Isothermal Amplification (SPIA)
  • 12.4. Nicking Enzyme Amplification Reaction (NEAR)
  • 12.5. Helicase-dependent Amplification (HDA)
  • 12.6. Transcription Mediated Amplification (TMA)
  • 12.7. Loop-mediated Isothermal Amplification (LAMP)
  • 12.8. Strand Displacement Amplification (SDA)
  • 12.9. Others

13. By End User

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 13.1.2. Market Attractiveness Index, By End User
  • 13.2. Hospitals and Clinics
    • 13.2.1. Introduction
    • 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 13.3. Diagnostic Center
  • 13.4. Research Laboratories
  • 13.5. Others

14. By Region

  • 14.1. Introduction
    • 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 14.1.2. Market Attractiveness Index, By Region
  • 14.2. North America
    • 14.2.1. Introduction
    • 14.2.2. Key Region-Specific Dynamics
    • 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.2.7.1. The U.S.
      • 14.2.7.2. Canada
      • 14.2.7.3. Mexico
  • 14.3. Europe
    • 14.3.1. Introduction
    • 14.3.2. Key Region-Specific Dynamics
    • 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.3.7.1. Germany
      • 14.3.7.2. The U.K.
      • 14.3.7.3. France
      • 14.3.7.4. Italy
      • 14.3.7.5. Spain
      • 14.3.7.6. Rest of Europe
  • 14.4. South America
    • 14.4.1. Introduction
    • 14.4.2. Key Region-Specific Dynamics
    • 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.4.7.1. Brazil
      • 14.4.7.2. Argentina
      • 14.4.7.3. Rest of South America
  • 14.5. Asia-Pacific
    • 14.5.1. Introduction
    • 14.5.2. Key Region-Specific Dynamics
    • 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.5.7.1. China
      • 14.5.7.2. India
      • 14.5.7.3. Japan
      • 14.5.7.4. Australia
      • 14.5.7.5. Rest of Asia-Pacific
  • 14.6. Middle East and Africa
    • 14.6.1. Introduction
    • 14.6.2. Key Region-Specific Dynamics
    • 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
    • 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

15. Competitive Landscape

  • 15.1. Competitive Scenario
  • 15.2. Market Share Analysis
  • 15.3. Mergers and Acquisitions Analysis

16. Company Profiles

  • 16.1. Thermo Fisher Scientific Inc.
    • 16.1.1. Company Overview
    • 16.1.2. Product Type Portfolio and Description
    • 16.1.3. Financial Overview
    • 16.1.4. Key Developments
  • 16.2. bioMerieux
  • 16.3. Becton, Dickinson & Company
  • 16.4. Lucigen
  • 16.5. Qiagen
  • 16.6. Quidel Corporation
  • 16.7. Eiken Chemical Co. Ltd
  • 16.8. Tecan Genomics Inc.
  • 16.9. Meridian Bioscience
  • 16.10. OptiGene Limited

LIST NOT EXHAUSTIVE

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us